Tin tức & Cập nhật
Xem bài viết Bệnh nhiễm khuẩn
Xem
Chỉ hiển thị Multimedia

Investigational drug gains upper hand over placebo in reducing CDI recurrence rates
20 May 2022
bởiAudrey Abella
SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.
20 May 2022

COVID-19 vaccine hesitancy persists in pregnant women despite recommendations
16 May 2022
bởiStephen Padilla
Acceptance rates of COVID-19 vaccines have remained unchanged among unvaccinated pregnant women following national recommendations, with nearly one-third of patients seeing the vaccine as something harmful to their pregnancy, according to a study.
16 May 2022

Oral tebipenem pivoxil hydrobromide works against complicated UTI, acute pyelonephritis
16 May 2022
Oral tebipenem pivoxil hydrobromide appears to be as good as intravenous ertapenem in the treatment of patients with complicated urinary tract infection (UTI) and acute pyelonephritis, with the two having a similar safety profile, according to data from a phase III study.
16 May 2022





